HopeStage
Back to all studies
Active Not RecruitingNCT06303739

Psilocybin-Assisted Therapy in Treatment-Resistant Depression

Medication studyAges 18–70United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
Chapel HillSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 19, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
20
Sponsor
University of North Carolina, Chapel Hill
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT06303739
Official title
Show the full official title

Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot Study

Recruitment & locations

Not recruiting

Chapel Hill

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of North Carolina, Chapel Hill, a university.

Does this study involve medication?

Yes. The study involves medication, including psilocybin.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies